SinanUYCanbolatIPBaydarO. Relationship between increased serum resistin level and severity of coronary artery disease. Angiology. 2014;65(3):239–242.
2.
MakniEMoallaWBenezzeddine-BoussaidiL. Correlation of resistin with inflammatory and cardiometabolic markers in obese adolescents with and without metabolic syndrome. Obes Facts. 2013;6(4):393–404.
3.
MeloneMWilsieLPalyhaOLacGTabkaZElloumiM. Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin/kexin type 9. J Am Coll Cardiol. 2012;59(19):1697–1705.
4.
PoirierSMayerGBenjannetS. The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2. J Biol Chem. 2008;283(4):2363–2372.
5.
HamptonENKnuthMWLiJHarrisJLLesleySASpraggonG. The self-inhibited structure of full-length PCSK9 at 1.9 a reveals structural homology with resistin within the C-terminal domain. Proc Natl Acad Sci U S A. 2007;104(37):14604–14609.
